The Netherlands
SoundCell is a pioneering startup founded in 2022 that leverages graphene technology for single cell resolution antibiotic sensitivity testing. Despite having no formal slogan, its focus on cutting-edge medical technology positions it uniquely in the health-tech sector.
In its early stages, SoundCell has gained significant traction by securing a substantial €2.50M grant investment from the European Innovation Council as of 01 December 2023. This financial backing not only underscores the innovative nature of the company's core technology but also highlights the confidence that prominent European entities have in its potential to revolutionize antibiotic sensitivity testing.
Although the company lacks detailed industry categorization and does not have a listed headquarters, its technological focus offers substantial opportunities for growth and scalability. Investors looking at transformative healthcare solutions may find SoundCell a notable contender for diversifying their portfolios in the biotech space.
